Standout Papers

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial... 2017 2026 2020 2023 412
  1. Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial (2017)
    Philip McGuire, Philip Robson et al. American Journal of Psychiatry

Immediate Impact

55 standout
Sub-graph 1 of 22

Citing Papers

Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
2025 Standout
GPCR drug discovery: new agents, targets and indications
2025 Standout
2 intermediate papers

Works of Rachel Barron being referenced

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
2017 Standout

Author Peers

Author Last Decade Papers Cites
Rachel Barron 451 61 134 121 6 537
Halle Thurnauer 436 36 94 228 5 520
D. Vasile 384 48 144 122 25 482
Amaya Austrich-Olivares 319 43 69 144 10 560
Lucy Walker 367 27 101 161 7 548
Fernanda Fiel Peres 360 42 59 244 17 519
Paul Bellman 342 39 33 117 5 514
Rachel Lees 512 33 126 188 25 634
Ariandra Guerini Sartim 345 35 67 211 15 522
Caroline A. MacCallum 538 31 72 83 20 643
Melissa J. Benson 293 17 130 155 18 581

All Works

Loading papers...

Rankless by CCL
2026